Cancer Chemotherapy Applications
-
Medical solutions for orthopedic implant manufacturing sector
Micron's ISO 13485 certified, FDA registered cGMP orthopedic implant manufacturing solutions include precision machining, finishing, porous coatings, passivation, and ...
By Micron Solutions based in Fitchburg, MASSACHUSETTS (USA).
-
The Chrysalis Solution to Mitigate Radiation Therapy-Induced Tissue Damage
Prescriptive Use To Mitigate Radiotherapy Damage To Normal Tissue and Allow More Effective Cancer Therapy. Almost 70% of all patients with cancer receive radiotherapy alone or in combination with surgery or chemotherapy. The amount of radiation that can be used to control tumor growth, however, is limited by normal tissue damage. Development of drugs to selectively reduce radiotherapy-induced normal tissue damage may improve post-therapy quality of life and allow more aggressive radiotherapy protocols to better ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
-
Patient-reported outcomes in oncology sector
Monitor quality of life and treatment effects to increase overall wellbeing. PROMs have become a prominent topic in healthcare innovation, especially in cancer care, via the direct evaluation of treatment outcomes from the patients' perspective. Patient-Reported Outcomes offer physicians a multitude of insights into cancer care processes through the perspective of the patient. Routine collection of PRO data in oncology can plan a pivotal role in improving clinical outcomes and the overall quality of ...
By Heartbeat Medical based in Berlin, GERMANY.
-
Delmitide
Delmitide is a TNF-alpha production inhibitor potentially for the treatment of chemotherapy-induced diarrhea. https://www.creative-peptides.com/product/delmitide-item-10-101-147-34916.html ...
By Creative Peptides based in New York, NEW YORK (USA).
-
IQ-Tip System for Patients
Precision means caring, and gives confidence to both patient and physician in times when lumbar puncture is a necessity. Less traumatic punctures may reduce unnecessary chemotherapy of the patient, and in the long term, it may reduce the risk of secondary cancers later in early adulthood. This can save costs now and in the ...
By Injeq Oy based in Tampere, FINLAND.
-
Immunoscore for Colon Cancer Patients
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
Novel microfluidic and bio-imaging technologies solutions for diagnostics areas
Building on our expertise in cell sorting tools incorporating shadow imaging for detection and characterization of cells, we are developing medical diagnostic devices leveraging these technologies, along with microfluidic integrated biosensors, to capture and quantify cells from unprocessed whole blood or other body fluids. This healthcare platform technology addresses significant underserved clinical needs in the home and primary care settings for innovative, inexpensive, accurate and easy-to-use point-of-care ...
By ZyMōt Fertility, Inc. based in Gaithersburg, MARYLAND (USA).
-
Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease
A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet need, including inflammatory bowel disease, chemotherapy-induced gut injury, food allergies, and celiac disease. We are advancing novel, oral, non-immunosuppressive therapeutics to improve GI barrier function. Our multi-targeted approach involves improving epithelial cell homeostasis, restoring appropriate immune responses, and repairing secretory cell ...
By Kallyope Inc. based in New York City, NEW YORK (USA).
-
Breast MRI System for Clinical Indications
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
By Aurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA).
-
BSD-2000 - Deep Regional Hyperthermia System for Clinical
Randomized clinical trials (RCT’s) have been shown significant improvement in clinical outcome when hyperthermia was added to radiotherapy and/or chemotherapy. In 2004 experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue ...
By Pyrexar based in Salt Lake City, UTAH (USA).
-
Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
By IntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA).
-
Quench - Aerosol Platform Technology for Lung Cancer
Despite the use of aggressive surgery and combination chemotherapy, lung cancer remains difficult to control and is the biggest killer among cancers at 154,000 annual US deaths. Lung cancer kills more people per year than prostate, pancreas, breast, and colon cancers combined. ...
By Quench Medical Inc. based in St Paul, MINNESOTA (USA).
-
Indications LLLT Application
The low level laser therapy is successfully used in nearly all areas of medicine. Numerous studies and long-term clinical experiences substantiate the efficacy of the low level laser ...
By Heltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA.
-
Highly customized aptamer discovery solutions for drug delivery sector
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you